T. Rowe Price Associates’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,532
| Closed | -$204K | – | 3075 |
|
|
2021
Q4 | $204K | Sell |
12,532
-17,609
| -58% | -$258K | ﹤0.01% | 2755 |
|
|
2021
Q3 | $458K | Buy |
30,141
+245
| +0.8% | +$3.83K | ﹤0.01% | 2415 |
|
|
2021
Q2 | $517K | Sell |
29,896
-1,199
| -4% | -$22.1K | ﹤0.01% | 2381 |
|
|
2021
Q1 | $607K | Buy |
31,095
+28
| +0.1% | +$574 | ﹤0.01% | 2281 |
|
|
2020
Q4 | $621K | Buy |
+31,067
| New | +$635K | ﹤0.01% | 2150 |
|
|
2020
Q3 | – | Sell |
-667,912
| Closed | -$18M | – | 2674 |
|
|
2020
Q2 | $18M | Sell |
667,912
-51,412
| -7% | -$1.42M | ﹤0.01% | 1172 |
|
|
2020
Q1 | $17.8M | Sell |
719,324
-619,965
| -46% | -$22.6M | ﹤0.01% | 1110 |
|
|
2019
Q4 | $69.8M | Buy |
1,339,289
+808,231
| +152% | +$37M | 0.01% | 784 |
|
|
2019
Q3 | $21.3M | Sell |
531,058
-289,091
| -35% | -$13.3M | ﹤0.01% | 1132 |
|
|
2019
Q2 | $39.2M | Sell |
820,149
-823,331
| -50% | -$33.2M | 0.01% | 967 |
|
|
2019
Q1 | $90.4M | Buy |
1,643,480
+588,315
| +56% | +$28M | 0.01% | 668 |
|
|
2018
Q4 | $38.5M | Sell |
1,055,165
-192,461
| -15% | -$7.88M | 0.01% | 916 |
|
|
2018
Q3 | $61.9M | Buy |
1,247,626
+172,381
| +16% | +$8.78M | 0.01% | 835 |
|
|
2018
Q2 | $47.5M | Buy |
1,075,245
+153,691
| +17% | +$6.33M | 0.01% | 917 |
|
|
2018
Q1 | $36.9M | Buy |
+921,554
| New | +$36.5M | 0.01% | 974 |
|
T. Rowe Price Associates's ZGNX Position: Q1 2022 in Review
T. Rowe Price Associates sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 12,532 shares — an estimated $204K sold.
T. Rowe Price Associates first reported a position in ZGNX in Q1 2018 and held it in 15 quarters. The position peaked at $90.4M in Q1 2019. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- T. Rowe Price Associates reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- T. Rowe Price Associates sold 12,532 Zogenix, Inc. shares in Q1 2022, an estimated $204K.
- T. Rowe Price Associates first reported a position in Zogenix, Inc. in Q1 2018 and held it in 15 quarters.
- T. Rowe Price Associates's Zogenix, Inc. position peaked at $90.4M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.